Access count of this item: 95

Files in This Item:
File Description SizeFormat 
37_1215.pdf291.28 kBAdobe PDFView/Open
Title: 腎細胞癌臨床成績の検討
Other Titles: A clinical study on renal cell carcinoma
Authors: 柳川, 眞  KAKEN_name
鈴木, 泉  KAKEN_name
亀田, 晃司  KAKEN_name
中野, 清一  KAKEN_name
金原, 弘幸  KAKEN_name
荒木, 富雄  KAKEN_name
桜井, 正樹  KAKEN_name
日置, 琢一  KAKEN_name
杉村, 芳樹  KAKEN_name
栃木, 宏水  KAKEN_name
川村, 寿一  KAKEN_name
山崎, 義久  KAKEN_name
Author's alias: Yanagawa, Makoto
Suzuki, Sen
Kameda, Kouji
Nakano, Seiichi
Kinbara, Hiroyuki
Araki, Tomio
Sakurai, Masaki
Hioki, Takuichi
Sugimura, Yoshiki
Tochigi, Hiromi
Kawamura, Juichi
Yamasaki, Yoshihisa
Keywords: Renal cell carcinoma
Clinical statistics
Issue Date: Oct-1991
Publisher: 泌尿器科紀要刊行会
Journal title: 泌尿器科紀要
Volume: 37
Issue: 10
Start page: 1215
End page: 1221
Abstract: 腎細胞癌95例について,男女比は3:1,平均年齢は男女共に61歳であった.主訴は血尿が最も多く44名,CT, USの普及による偶然発見者は18例あった.5年,10年の生存は49名,35名で,stage別の5年生存は1:35/42名,2:4/8名,3:4/21名,4:1/24名となった.生存率は,1)リンパ節転移の有無で有意差あり(P<0.01),2)遠隔転移の有無でも有意差あり(P<0.01),3)静脈浸潤の有無では有意差がなかった.4)各細胞型群間には有意差なく,5)術前の腎動脈塞栓術の有無にも有意差はなかった.各治療群(MMC, VBL, BRM)間に有意差はなかったが,VBLで生存率がやや良好であった
A retrospective study was carried out on 95 patients affected with renal cell carcinoma (RCC) between January 1973 and December 1988. Male to female ratio was 3 to 1 and the average age was 61 years. Hematuria was the most common initial symptom (44 patients, 46.3%), followed by incidental findings (18 patients, 18.9%). Five- and 10-year survival rates for all patients with RCC were 51.9 and 37.1%, respectively. Five-year survival rates for stage I, II, III, and IV were 82.7 54.7, 20.0, and 4.7%, respectively. Statistical analyses identified variables that significantly influenced survival, including lymph node metastasis (p less than 0.01) and distant metastasis (p less than 0.01). Cell type and renal vein involvement did not influence survival significantly. The three different forms of therapy (mitomycin therapy vincristine therapy and immunological therapy) did not influence survival significantly, but the beneficial effect of VBL therapy was obtained.
PubMed ID: 1755414
Appears in Collections:Vol.37 No.10

Show full item record

Export to RefWorks

Export Format: 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.